Applied Microbiology Inc. said that it has granted BabsonBrothers, its strategic partner, an exclusive license to marketConsept bovine teat dip in Mexico, and non-exclusive licensesfor Latin America, Switzerland, Korea and Taiwan.

Consept is a preventative for bovine mastitis based onApplied's Ambicin bactericide. According to the New Yorkcompany, bovine mastitis results in lost milk production of $35billion annually worldwide.

Babson of Naperville, Ill., said it will sell about 120,000 gallonsof Consept in the last six months of this year, about double itsoriginal projections. U.S. sales began in July.

Babson anticipates selling about 500,000 gallons of Consept in1992. Royalties to Applied on projected sales would be about$350,000.

CFPI of France will also introduce the teat dip in nine Europeancountries in 1992.

Applied could turn its first profit in 1992, said Chairman DavidGuttmann. Profits would be based on sales of Consept and anAmbicin-based underarm deodorant being developed byBeiersdorf GmbH, which may reach the market next year.

Applied Micro shares (NASDAQ:AMBI) closed off 13 cents at$4.75 on Wednesday. -- KB

(c) 1997 American Health Consultants. All rights reserved.